Adamis Pharmaceuticals Corporation (ADMP)
NASDAQ: ADMP · Delayed Price · USD
0.461
0.014 (3.18%)
At close: May 27, 2022 4:00 PM
0.450
-0.011 (-2.386%)
After-hours:May 27, 2022 5:20 PM EDT
Ratios and Metrics (Annual)
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | Current | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 | 2012 | 2011 | 2010 - 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Capitalization | 69 | 90 | 45 | 43 | 106 | 147 | 68 | 73 | 67 | 69 | 22 | Upgrade |
| Market Cap Growth | - | 98.26% | 5.25% | -59.43% | -27.57% | 116.06% | -6.26% | 8.92% | -3.39% | 214.99% | - | Upgrade |
| Enterprise Value | 52 | 68 | 43 | 38 | 90 | 134 | 70 | 68 | 62 | 70 | 22 | Upgrade |
| PE Ratio | - | -1.97 | -0.92 | -1.57 | -2.73 | -5.75 | -3.27 | -5.34 | -8.16 | -9.58 | -4.45 | Upgrade |
| PS Ratio | 14.48 | 40.78 | 16.36 | 1.95 | 7.05 | 11.24 | 10.50 | - | - | - | - | Upgrade |
| PB Ratio | 4.34 | 3.48 | 12.99 | 1.31 | 2.28 | 3.72 | 2.69 | 7.79 | 5.46 | -15.92 | -8.03 | Upgrade |
| EV/Sales Ratio | 10.88 | 28.11 | 14.38 | 1.60 | 5.11 | 9.77 | 10.33 | - | - | - | - | Upgrade |
| EV/EBITDA Ratio | - | - | - | - | - | - | - | - | 81.78 | - | - | Upgrade |
| EV/EBIT Ratio | - | - | - | - | - | - | - | - | 133.27 | - | - | Upgrade |
| Debt / Equity Ratio | 0.04 | 0.03 | 1.20 | 0.12 | 0.06 | 0.13 | 0.29 | 0 | 0.03 | -0.27 | -0.11 | Upgrade |
| Debt / EBITDA Ratio | -0.02 | -0.02 | -0.09 | -0.17 | -0.07 | -0.22 | -0.35 | 0 | 0.55 | -0.24 | -0.06 | Upgrade |
| Debt / FCF Ratio | -0.01 | -0.02 | -0.20 | -0.18 | -0.07 | -0.29 | -0.35 | 0 | -0.06 | -0.46 | -0.09 | Upgrade |
| Current Ratio | 2.05 | 3.14 | 0.63 | 1.48 | 2.23 | 2.44 | 0.82 | 1.51 | 1.85 | 0.08 | 0.01 | Upgrade |
| Asset Turnover | 0.11 | 0.04 | 0.07 | 0.44 | 0.28 | 0.28 | 0.22 | 0 | 0 | 0 | 0 | Upgrade |
| Return on Equity (ROE) | -132.80% | -113.00% | -226.50% | -74.90% | -95.50% | -72.80% | -112.80% | -100.10% | -263.60% | 170.40% | 239.60% | Upgrade |
| Return on Assets (ROA) | -91.90% | -80.50% | -123.70% | -54.90% | -73.70% | -55.10% | -71.40% | -85.40% | -87.00% | -750.70% | -1314.60% | Upgrade |
| Return on Capital (ROIC) | -695.50% | -687.90% | -444.60% | -175.80% | -491.60% | -421.60% | -1049.80% | 649.10% | -12.30% | 171.00% | 250.40% | Upgrade |
| Earnings Yield | -59.11% | -50.88% | -108.71% | -63.73% | -36.66% | -17.39% | -30.61% | -18.71% | -12.25% | -10.44% | -22.46% | Upgrade |
| FCF Yield | -59.51% | -43.31% | -47.00% | -52.71% | -34.01% | -11.71% | -31.30% | -14.25% | -10.33% | -3.71% | -15.29% | Upgrade |
| Buyback Yield / Dilution | -15.57% | -85.84% | -45.63% | -36.27% | -37.87% | -61.99% | -30.25% | -79.32% | -27.89% | -11.31% | -40.28% | Upgrade |
| Total Shareholder Return | -15.57% | -85.84% | -45.63% | -36.27% | -37.87% | -61.99% | -30.25% | -79.32% | -27.89% | -11.31% | -40.28% | Upgrade |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).